https://bcl-2inhibitors.com/ve....rsion-of-contingency
The therapeutic efficacy and negligible systemic toxicity of PS@Cu9S8 nanocatalysts were corroborated by in-vivo investigations. The research presented in this work not only includes the development of a superior multifunctional nanocatalyst for concurrent photothermal and chemodynamic tumor treatment, but also describes a facile approach for the construction of high-performance agents for cancer therapy. The first experimental synthesis of Na2MgScF7 (NMSF)